Jack Shteamer, MD
Anesthesiology · Philadelphia, PANPI 1629428024
Payments from drug & device makers
Across 38 payments — averaging $143.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$2K
- Bioventus LLC$1K
- Nevro Corp.$318
- Medtronic$211
- Providence Medical Technology, Inc.$39
What the payments were for
- Travel & lodging$3,08356%
- Food & beverage$2,38544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $2,369 |
| Boston Scientific | 14 | $1,528 |
| Bioventus LLC | 3 | $1,004 |
| Nevro Corp. | 4 | $318 |
| Medtronic | 3 | $211 |
| Providence Medical Technology, Inc. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$2,041
- Stimrouter Implantable Kit$974
- WAVEWRITER ALPHA$554
- WaveWriter Alpha Prime 16$523
- GENERAL PAIN MANAGEMENT$150
- Senza$134
- INTELLIS ADAPTIVESTIM$110
- Omnia$106
How this compares
$5,468 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 151 | $2,898 |
| Fentanyl | 15 | $2,616 |
| Gabapentin | 197 | $2,127 |
| Duloxetine Hcl | 94 | $1,277 |
| Lidocaine | 17 | $1,029 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $779 |
| Celecoxib | 11 | $629 |
| Tizanidine Hcl | 46 | $423 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $402 |
| Methocarbamol | 26 | $398 |
| Cyclobenzaprine Hcl | 41 | $354 |
| Amitriptyline Hcl | 14 | $296 |
| Baclofen | 17 | $267 |
| Oxycodone Hcl | 38 | $264 |
| Hydromorphone Hcl | 13 | $163 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Philadelphia
- Lee FleisherPhiladelphia$659K
- Huafeng WeiPhiladelphia$543K
- Joshua AtkinsPhiladelphia$467K
- Eugene ViscusiPhiladelphia$398K
- Gaurav MalhotraPhiladelphia$275K
- Michael ScottPhiladelphia$250K
- Jeffrey JosephPhiladelphia$213K
- Neil BristerPhiladelphia$206K
- Emily MackayPhiladelphia$166K
- Jacob RaphaelPhiladelphia$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.